Case Report
Accepted on 09 Sep 2026
Bilateral Subacute Subdural Hematoma as a Complication of T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Case Report
in Blood Cancer
Frontiers in Hematology
- 114 views
- Frontiers in Hematology
- Blood Cancer
- Articles
Type at least 3 characters
98 articles
articles
Editorial
Published on 31 Aug 2026
Editorial: New molecular targets for personalized treatment for low-grade non-hodgkin lymphoma
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1959952
- 677 views
Case Report
Accepted on 03 Jul 2026
Classical Hodgkin Lymphoma Presenting with Aortic Arch Encasement and C7–T1 Neural Foraminal Extension: A Rare Case Report
in Blood Cancer
Frontiers in Hematology
- 912 views
Review
Published on 26 Jun 2026
Crosstalk of factors underlying bone marrow niche-mediated chemoprotection in acute myeloid leukemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1850831
- 1,383 views
Case Report
Published on 24 Jun 2026
Right atrial thrombus in treatment-naive patient with an early-stage classical Hodgkin lymphoma: a case report and review of the literature
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1874214
- 939 views
Original Research
Published on 22 Jun 2026
Associations with the quality of life of adult family members or partners (informal carers) of people with leukaemia: results from a cross-sectional online global survey
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1813321
- 1,226 views
Original Research
Published on 11 Jun 2026
Matched comparison of therapeutic DLI and second allogeneic transplantation after relapse of acute leukemia or MDS
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1826416
- 1,316 views
Hypothesis and Theory
Published on 10 Jun 2026
The cells of origin of the chemotherapy-curable malignancies are highly sensitive to cytotoxic chemotherapy-mediated cell death
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1814036
- 1,538 views
Original Research
Published on 21 May 2026
A pilot study on therapeutic drug monitoring of asparaginase in Indian children with high-risk ALL: evidence for suboptimal exposure
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1779396
- 1,650 views
Mini Review
Published on 13 May 2026
Mechanisms of kinase inhibitor resistance in subtypes of cutaneous T-cell lymphomas
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1812908
- 1,619 views
Original Research
Published on 04 May 2026
Optimisation of patient-reported outcome measurement for haematological cancer patients receiving novel immunotherapies: perspectives of multi-stakeholders
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1800304
- 1,692 views
Case Report
Published on 08 Apr 2026
Case Report: A converging pathology: Chediak–Higashi syndrome and IEI-associated lymphoproliferative disease
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1650494
- 2,660 views
Review
Published on 31 Mar 2026
Revisiting old drugs and drug combinations for polycythemia vera and related neoplasms
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1749376
- 7,227 views
Case Report
Published on 30 Mar 2026
Case Report: Burkitt’s lymphoma with concurrent HIV, CMV encephalitis, and salmonella bacteremia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1727954
- 1,798 views
Original Research
Published on 16 Mar 2026
Living with chronic lymphocytic leukaemia: patient perspectives from a global online cross-sectional survey on care pathways and impacts on quality of life
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1794624
- 2,905 views
Case Report
Published on 23 Feb 2026
Case Report: two cases of idiopathic plasmacytic lymphadenopathy subtype of idiopathic multicentric Castleman disease with xanthelasma palpebrum from a Canadian center
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1745884
- 1,650 views
- 2 citations
Case Report
Published on 23 Feb 2026
Rapid response to obinutuzumab and venetoclax in patients with nephrotic syndrome related to CLL: a report of two cases
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1776722
- 1,230 views
Original Research
Published on 12 Feb 2026
Evaluating role of TNF-α in tyrosine kinase inhibitors-treated chronic myeloid leukemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1709697
- 1,784 views
Case Report
Published on 04 Feb 2026
Case Report: Chronic myelomonocytic leukemia initially diagnosed as immune thrombocytopenia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1748301
- 2,060 views
Original Research
Published on 30 Jan 2026
Long-term outcomes of hyperbaric oxygen pretreatment in autologous hematopoietic stem cell transplantation
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2026.1733667
- 2,921 views
Case Report
Published on 23 Jan 2026
Case Report: Durable response to PD-1 blockade after failure of ALK-targeted therapy and chemoimmunotherapy in ALK-positive large B-cell lymphoma
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1683981
- 2,060 views
Original Research
Published on 21 Jan 2026
Too soon to switch? Early TKI switching vs. continuous monotherapy: long-term outcomes in chronic myeloid leukemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1730554
- 2,312 views
Original Research
Published on 12 Jan 2026
Myeloma patients’ attitudes and perceived burden of treatment administration routes and locations: insights from a pan-European survey
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1699930
- 3,346 views
Review
Published on 07 Jan 2026
To treat or not to treat: a state-of-the-art overview of smoldering multiple myeloma
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1706219
- 4,490 views